This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

NICE guidance - use of nicotine replacement therapy (NRT) , cytisinicline, varenicline and bupropion for smoking cessation

Authoring team

Summary points of the NICE guidance include:

  • offer cytisinicline, NRT, varenicline or bupropion, as appropriate, to people who are planning to stop smoking
  • offer advice, encouragement and support, including referral to the NHS Stop Smoking Service, to help people in their attempt to quit
  • cytisinicline, NRT, varenicline or bupropion should normally be prescribed as part of an abstinent-contingent treatment, in which the smoker makes a commitment to stop smoking on or before a particular date (target stop date)
    • For adults, prescribe or provide bupropion, cytisinicline, NRT or varenicline before they stop smoking, and for:
      • bupropion, agree a quit date set within the first 2 weeks of treatment and reassess the person shortly before the prescription ends
      • cytisinicline, agree a quit date set within the first 5 days of treatment and reassess the person shortly before the prescription ends
      • NRT, agree a quit date and ensure the person has NRT ready to start the day before the quit date
      • varenicline, agree a quit date and start the treatment 1 to 2 weeks before this date; reassess the person shortly before the prescription ends
  • consider NRT for young people aged 12 and over who are smoking and dependent on tobacco
    • if this is prescribed, offer it with behavioural support
  • do not offer cytisinicline, varenicline or bupropion should be offered to young people under 18 nor to pregnant or breastfeeding women
  • do not offer cytisinicline to people aged 66 and over
  • do not offer NRT, varenicline or bupropion in any combination
  • advise people (as appropriate for their age) that the following options, when combined with behavioural support, are more likely to result in them successfully stopping smoking:
    • cytisinicline
    • a combination of short-acting and long-acting NRT
    • varenicline
    • nicotine-containing e-cigarettes

Notes

  • cytisinicline is sometimes referred to as cytisine

Reference:

  • (1) NICE (February 2025). Tobacco: preventing uptake, promoting quitting and treating dependence. www.nice.org.uk

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.